Sitemap
November 06, 2023 Articles
Filter by Available Specialty
- At same PSA level, Black men more likely than white men to have prostate cancer
- Atezolizumab-bevacizumab combo extends survival among certain women with cervical cancer
- BLOG: Financial toxicity — how did we get here?
- Brilaroxazine shows promise for schizophrenia in pivotal phase 3 trial
- COVID-19 pandemic not linked to changes in overall parental vaccine hesitancy
- Discharge to skilled nursing facility led to higher readmission rates vs. home health care
- Epion Therapeutics commences phase 3 clinical trials for EpiSmart keratoconus treatment
- Exposure to nitrogen dioxide, particulate matter increases miscarriage risk
- FDA warns people with diabetes to avoid product sold for blood glucose management
- GALAXI 1: Continued subcutaneous Tremfya benefits IV induction non-responders with Crohn’s
- Hooked on Primary Care with Tammie Koehler, DO
- How diet, lifestyle can prolong aging
- Imeka receives investment from ADDF to develop novel biomarkers for Alzheimer’s disease
- Lifestyle medicine foundation for treating people with obesity
- Low-dose atropine slows myopia progression in children aged 3 to 17 years
- Lower educational attainment linked to lifetime CVD risk
- Not implementing generic PrEP programs for young MSM would be ‘throwing away’ lives, money
- Novel bioabsorbable scaffold for tibial vessels safe in first-in-human study
- Novel, plant-based serum may improve signs of photoaging
- Office-based ophthalmic surgery can be performed safely
- Once-daily elagolix significantly reduces heavy menstrual bleeding for premenopausal women
- One in five immunosuppressed patients lack any response after three COVID vaccine doses
- One-stage approach for PJI treatment had similar success rates as two-stage approach
- Outreach critical to finding underserved patients with cataracts
- Political ideology linked with trust in public health agencies for cancer information
- Positive phase 1 results in trial of novel therapy for spinal and bulbar muscular atrophy
- Q&A: Shaping the future of lung transplantation with technology
- RECELL system efficacious in vitiligo repigmentation
- Remibrutinib safe, effective for chronic spontaneous urticaria over 52 weeks
- Small-molecule therapy fails to improve efficacy in brain cancer trial
- Study: Higher medication nonadherence for Black vs. white adults with glomerular disease
- Switch to ticagrelor monotherapy after 3-month DAPT safely reduces bleeding after PCI
- Telemedicine follow-up for positive airway pressure shows adherence benefits
- Tezepelumab reduces asthma exacerbations season by season
- Tezepelumab reduces asthma exacerbations season by season
- Top in cardiology: GLP-1 receptor agonist roundup; CV heat deaths expected to spike
- Upadacitinib ‘may be better choice’ vs. ustekinumab for UC remission by week 16
- VIDEO: Avacincaptad pegol shows positive GA reduction, safety profile at 2 years
- VIDEO: Child Neurology Society addresses sexual, gender minority health care
- VIDEO: CLEK study data continues to shape keratoconus management
- VIDEO: Conference reviews year of advances in child neurology
- VIDEO: IOL with bimatoprost-delivery platform shows promise for long-term IOP lowering
- VIDEO: Methicillin resistance present in approximately 40% of endophthalmitis isolates